Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piroxicam mesotherapy versus shockwave therapy for knee osteoarthritis
IRCT20250622066221N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of piroxicam and lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
piroxicamlidocaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20250622066221N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250622066221N1.